Kovack Advisors’s CVS Health CVS Stock Holding History

Kovack Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14	Closed	-$4K	–	496
2019 Q3	$4K	Buy	14 +2	+17%	+$119	﹤0.01%	488
2019 Q2	$2K	Sell	12 -5	-29%	-$269	﹤0.01%	461
2019 Q1	$4K	Buy	+17	New	+$1.05K	﹤0.01%	436
2018 Q3	–	Sell	-8	Closed	-$4K	–	482
2018 Q2	$4K	Buy	+8	New	+$527	﹤0.01%	413
2017 Q4	–	Sell	-5	Closed	-$1K	–	462
2017 Q3	$1K	Sell	5 -1	-17%	-$79	﹤0.01%	354
2017 Q2	$2K	Hold	6	–	–	﹤0.01%	371
2017 Q1	$2K	Sell	6 -6	-50%	-$479	﹤0.01%	293
2016 Q4	$2K	Buy	+12	New	+$971	﹤0.01%	253
2016 Q3	–	Sell	-10	Closed	-$2K	–	277
2016 Q2	$2K	Hold	10	–	–	﹤0.01%	258
2016 Q1	$7K	Buy	10 +7	+233%	+$681	﹤0.01%	229
2015 Q4	$2K	Buy	3 +2	+200%	+$196	﹤0.01%	218
2015 Q3	$1K	Hold	1	–	–	﹤0.01%	215
2015 Q2	$2K	Hold	1	–	–	﹤0.01%	206
2015 Q1	$2K	Hold	1	–	–	﹤0.01%	179
2014 Q4	$2K	Buy	+1	New	+$88	﹤0.01%	160

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kovack Advisors's CVS Position: Q1 2026 in Review

Kovack Advisors reduced its CVS Health (CVS) stake by 12% in Q1 2026, selling an estimated $129K and leaving 12,425 shares worth $898K. The position accounts for 0.05% of the portfolio, ranked #400.

Kovack Advisors first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.15M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Kovack Advisors held 12,425 shares of CVS Health worth $898K as of Q1 2026.
Kovack Advisors sold 1,669 CVS Health shares in Q1 2026, an estimated $129K.
CVS Health made up 0.05% of Kovack Advisors's portfolio in Q1 2026, its #400 holding.
Kovack Advisors first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
Kovack Advisors's CVS Health position peaked at $2.15M in Q1 2024.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.